COVID-19 Business Questions & Resources
Learn More
Woman presenting to a group

Let's take a look at recent Life Sciences wins for the Indianapolis region.

Novartis Subsidiary Announces New Plant - Indianapolis - June 2020


INDIANAPOLIS - Advanced Accelerator Applications, a subsidiary of global healthcare giant Novartis AG, has announced plans to build a 50,000-square-foot manufacturing plant near Indianapolis International Airport, hiring as many as 50 people to staff the facility.

Financial details were not disclosed.

 

This will be the company’s second U.S. manufacturing site for currently approved therapy and pipeline drug candidates.

 

The Radioligand Therapy manufacturing plant will be located within the Purdue Research Park in Indianapolis. The site will produce targeted radioligand drugs used in the treatment of cancer.

 

“We believe that Radioligand Therapy has the potential to become a major pillar of cancer treatment. We are also proud to support the communities in which we operate by creating skilled jobs and promoting economic growth," said Sidonie Golombowski-Daffner, chair and president, Advanced Accelerator Applications.

 

AAA said the facility will significantly expand the company’s manufacturing capacity in the U.S. and will feature state-of-the-art, advanced manufacturing technologies. The company says the treatment targets specific tumor cells and has less of an impact on surrounding healthy tissue.

 

The company expects operations to begin in 2023.

Eli Lilly & Co. - Indianapolis - November 2019


In the late months of 2019, Eli Lilly and Co. announced plans to invest $400 million in order to expand drug-manufacturing facilities at its Lilly Technology Center campus in Indianapolis. The expansion, which will add 100 high-paying jobs, will help the company keep up with demand for current medicines and new drugs expected to emerge from its pharmaceutical pipeline.

According to Lilly’s senior vice president and president of manufacturing operations, Myles O’Neill, the new employees will include scientists, engineers, and skilled technicians.

LifeNet Health - Plainfield - October 2019


LifeNet Health, a company that specializes in organ and tissue transplantation, has invested $18 million to set up a 70,000-square-foot biologics logistics center in Planfield. The expansion into central Indiana will result in the hiring of more than 127 people by the end of 2023.

The Indiana Economic Development Corp. offered up to $1.25 million in conditional tax credits and $100,000 in training grants. The incentives are contingent upon the company’s job-creation plans. The town of Plainfield will consider additional incentives at the request of the Hendricks County Economic Development Commission.

Abbott Laboratories - Westfield - October 2019


Medical device manufacturer, Abbott Laboratories, announced plans to open a medical device manufacturing facility in Westfield, IN. Abbott’s investment of more than $37.6 million will yield a 120,000-square-foot facility in the NorthPoint Industrial Park along U.S. 31. The jobs, which range from assemblers to engineers, will pay an average wage of $27 per hour.

The Indiana Economic Development Corporation (IEDC) offered Abbott up to $3.5 million in conditional tax credits and up to $1 million in training grants based on the company’s plans to create more than 300 jobs by the end of 2024. These incentives are contingent upon Abbott’s ability to meet hiring goals. Additionally, the IEDC offered up to $750,000 to the community from the Industrial Development Grant Fund to support improvements to the site’s infrastructure. Duke Energy Corp. also approved incentives to help offset a portion of energy costs. The city of Westfield will consider additional incentives.